Security key
14817C107
FILANA THERAPEUTICS, INC. - Common Stock (FLNA)
CUSIP: 14817C107
Q2 2020 13F Holders as of 30 Jun 2020
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 5,994,033
- Total 13F value
- $18,463,673
- Share change
- -14,281
- Put/Call ratio
- 76%
- SEC-reported price per share
- $3.08
- Number of holders
- 47
- Value change
- -$2,167,955
- Number of buys
- 38
- Number of sells
- 19
- Shares outstanding
- 48,331,225
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2020
Institutions
47
Top holders
10
FLNA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2020
Previous quarter: Q1 2020
FILANA THERAPEUTICS, INC. SEC filings
FILANA THERAPEUTICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 14817C107
Recent filing periods:
Ownership snapshot
Top reported holders of FLNA - FILANA THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Bleichroeder LP
Disclosed value leader
Bleichroeder LP
Comparable rows
15/15
Latest evidence
31 Mar 2020
13F
Lead comparable stake: 3.6%
Showing 1-6 of 15 holder rows.
Quick read
Bleichroeder LP leads the comparable SEC ownership view at 3.6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Bleichroeder LP's linked filing trail.
Comparable ownership
Top 5
Bleichroeder LP
3.6%
VANGUARD GROUP INC
1.7%
RENAISSANCE TECHNOLOGIES LLC
1.4%
SPHERA FUNDS MANAGEMENT LTD.
1.3%
UBS Group AG
0.62%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Bleichroeder LP |
13F
Company
|
3.6%
|
$7,150,000
1,739,540 shares
|
— | 31 Mar 2020 |
| VANGUARD GROUP INC |
13F
Company
|
1.7%
|
$3,427,000
834,041 shares
|
— | 31 Mar 2020 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
1.4%
|
$2,687,000
653,759 shares
|
— | 31 Mar 2020 |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
Company
|
1.3%
|
$2,528,000
615,000 shares
|
— | 31 Mar 2020 |
| UBS Group AG |
13F
Company
|
0.62%
|
$1,234,000
300,290 shares
|
— | 31 Mar 2020 |
| Ikarian Capital, LLC |
13F
Company
|
0.62%
|
$1,233,000
300,000 shares
|
— | 31 Mar 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
47
Shares
5,994,033
Rows available
47
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
38
Q2 2020 holders
47
Holder diff
9
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 value | Q2 2020 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend